ro tirzepatide Zepbound™ (Tirzepatide) Now Available Through Body Program Eli Lilly strikes Zepbound deal

Concerns medical weight-loss treatments are being advertised to vulnerable eating disorder patients Mon 29 Dec 2025 at 6:47am , updated Mon 29 Dec 2025 at 10:11am Peak eating disorder bodies are raising concerns about the rapid rollout of GLP-1 weight-loss treatments through telehealth, and what they describe as aggressive social media marketing by some companies

Read more: To view or add a comment, sign in This case highlights the importance of post-market monitoring and transparency in regulatory processes to ensure the continued safety and effectiveness of products after their approval

Pair your collagen with a source of Vitamin C, stay hydrated, and if you want to round out your stack, explore the Boosts Collection

Ozempic is for type 2 diabetes management, while Wegovy is tailored for weight loss

K.WilsonJ

Since no water is present, chemical reactions (e.g., hydrolysis) occur much more slowly